AstraZeneca PLC Files 6-K for Director Shareholding
Ticker: AZN · Form: 6-K · Filed: Aug 18, 2025 · CIK: 901832
| Field | Detail |
|---|---|
| Company | Astrazeneca PLC (AZN) |
| Form Type | 6-K |
| Filed Date | Aug 18, 2025 |
| Risk Level | low |
| Pages | 2 |
| Reading Time | 3 min |
| Key Dollar Amounts | $0.25 |
| Sentiment | neutral |
Sentiment: neutral
Topics: insider-filing, disclosure, regulatory-filing
Related Tickers: AZN
TL;DR
AZN filed a 6-K on Aug 18, 2025, detailing director and PDMR shareholdings. Standard disclosure.
AI Summary
AstraZeneca PLC filed a Form 6-K on August 18, 2025, reporting its shareholding information for Directors and PDMRs (Persons Discharging Managerial Responsibilities). The filing is a routine report for the month of August 2025, submitted under the Securities Exchange Act of 1934.
Why It Matters
This filing provides transparency into the shareholdings of key company personnel, which can offer insights into insider confidence and potential future stock movements.
Risk Assessment
Risk Level: low — This is a routine disclosure of director and PDMR shareholdings, which is standard practice and does not indicate any new material risks.
Key Players & Entities
- AstraZeneca PLC (company) — Filer of the Form 6-K
- 001-11960 (company) — SEC File Number for AstraZeneca PLC
- August 2025 (date) — Reporting period for the Form 6-K
- 20250818 (date) — Filing date of the Form 6-K
FAQ
What type of report is this Form 6-K?
This Form 6-K is a Report of Foreign Issuer filed pursuant to Rule 13a-16 or 15d-16 of the Securities Exchange Act of 1934.
What is the filing date of this report?
The filing date of this report is August 18, 2025.
What is the reporting period covered by this Form 6-K?
The reporting period covered by this Form 6-K is the month of August 2025.
What is the SEC file number for AstraZeneca PLC?
The SEC file number for AstraZeneca PLC is 001-11960.
What is the primary purpose of this filing?
The primary purpose of this filing is to report shareholding information for Directors and Persons Discharging Managerial Responsibilities (PDMRs) of AstraZeneca PLC.
Filing Stats: 689 words · 3 min read · ~2 pages · Grade level 19.2 · Accepted 2025-08-18 11:07:43
Key Financial Figures
- $0.25 — ion in the Company's ordinary shares of $0.25 each (Ordinary Shares), by Aradhana Sar
Filing Documents
- a7666v.htm (6-K) — 44KB
- 0001654954-25-009748.txt ( ) — 45KB
SIGNATURES
SIGNATURES   Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.     AstraZeneca PLC     Date: 18 August 2025     By: /s/ Matthew Bowden   Name: Matthew Bowden   Title: Company Secretary